JOSEPH D. KEEGAN - 27 Oct 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Joseph D. Keegan pursuant to Power of Attorney previous filed
Issuer symbol
TECH
Transactions as of
27 Oct 2022
Transactions value $
$0
Form type
4
Filing time
31 Oct 2022, 17:19:50 UTC
Previous filing
01 Nov 2021
Next filing
30 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +338 +14.49% $0.00 2.67K 27 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +865 $0.00 865 27 Oct 2022 Common Stock 865 $295.77 Direct F1
holding TECH Stock Options (Right to Buy) 3.13K 27 Oct 2022 Common Stock 3.13K $125.05 Direct
holding TECH Stock Options (Right to Buy) 1.9K 27 Oct 2022 Common Stock 1.9K $179.84 Direct
holding TECH Stock Options (Right to Buy) 2.01K 27 Oct 2022 Common Stock 2.01K $201.64 Direct
holding TECH Stock Options (Right to Buy) 1.51K 27 Oct 2022 Common Stock 1.51K $255.69 Direct
holding TECH Stock Options (Right to Buy) 633 27 Oct 2022 Common Stock 633 $515.24 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.